Soho Global Health Tbk PT
IDX:SOHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (14.5), the stock would be worth Rp872.28 (56% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 32.7 | Rp1 970 |
0%
|
| 3-Year Average | 14.5 | Rp872.28 |
-56%
|
| 5-Year Average | 14.4 | Rp867.35 |
-56%
|
| Industry Average | 11.7 | Rp706.23 |
-64%
|
| Country Average | 7.8 | Rp470.24 |
-76%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
|
Soho Global Health Tbk PT
IDX:SOHO
|
25T IDR | 32.7 | 41.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 28.7 | 42.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563.9B USD | 17.2 | 26.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.7 | 19.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.5B GBP | 16.5 | 29.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.7B USD | 10 | 16.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228B CHF | 12.6 | 20.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 8.2 | 11.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.7B USD | 7.7 | 20.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.1B USD | 7.2 | 17.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.4 |
| Median | 7.8 |
| 70th Percentile | 13.9 |
| Max | 1 547 003.1 |
Other Multiples
Soho Global Health Tbk PT
Glance View
PT SOHO Global Health engages in the provision of healthcare services. The company is headquartered in Jakarta, Dki Jakarta and currently employs 2,373 full-time employees. The company went IPO on 2020-09-08. The firm operates through five segments: Distribution, Professional product, Consumer health, Alliance and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. Its product portfolio ranged from wound care, hospital general care, surgery, orthopedics and in-vitro diagnostics.
